Naturetin Related Published Studies
Well-designed clinical trials related to Naturetin (Bendroflumethiazide)
Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study. [2006]
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. [2005.09.10]
Well-designed clinical trials possibly related to Naturetin (Bendroflumethiazide)
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen. [2008.02]
The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. [2007.07.17]
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report. [2007.02]
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition. [2007.02]
Comparison of the effect of diuretics on carotid blood flow in stroke patients. [2006.03]
Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. [2005.10]
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. [2005.09]
Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension. [2005.06]
Differential cognitive outcomes in the Hypertensive Old People in Edinburgh study. [2005.03.15]
Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. [2005.01]
Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period. [2005]
Other research related to Naturetin (Bendroflumethiazide)
Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. [2008.08]
Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study. [2007.05.09]
[Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trail: blood pressure lowering arm) study results--multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy i hypertension? (comment)] [2005.12]
Other possibly related research studies
Thiazide diuretic prescription and electrolyte abnormalities in primary care. [2006.01]
Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? [2005.12]
[Old or new antihypertensives--which are better?] [2005.03.31]
[The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers] [2006.04.22]
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels. [2006.01]
[New tendencies in combination antihypertensive therapy] [2005.11.17]
Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites--analysis of glass transition composition relationships. [2005.04]
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors a substudy of the anglo-scandinavian cardiac outcomes trial. [2007.06]
Flecainide cardiotoxicity precipitated by electrolyte imbalance. Caution with thiazide diuretics. [2007.05]
Delayed cardiotoxicity in chronic lithium poisoning: discrepancy between serum lithium concentrations and clinical status. [2007.05]
Economic Evaluation of ASCOT-BPLA: Antihypertensive treatment with an amlodipine-based regimen is cost-effective compared to an atenolol-based regimen. [2007.10.04]
Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients. [2007.11]
Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study. [2008.05]
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. [2008.02]
Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. [2008.09]
[Hypertension--does it matter how blood pressure is lowered?] [2008.09.01]
Upregulation of apical sodium-chloride cotransporter and basolateral chloride channels is responsible for the maintenance of salt-sensitive hypertension. [2008.08]
|
